Found: 187
Select item for more details and to access through your institution.
Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies.
- Published in:
- Archives of Dermatological Research, 2023, v. 315, n. 7, p. 2035, doi. 10.1007/s00403-023-02541-5
- By:
- Publication type:
- Article
Testing a candidate composite serum protein marker of skin severity in systemic sclerosis.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 2, p. 1, doi. 10.1093/rap/rkae039
- By:
- Publication type:
- Article
Management of systemic sclerosis: British Society for Rheumatology guideline scope.
- Published in:
- Rheumatology Advances in Practice, 2023, v. 7, n. 1, p. 1, doi. 10.1093/rap/rkad022
- By:
- Publication type:
- Article
Exploring molecular pathology of chronic kidney disease in systemic sclerosis by analysis of urinary and serum proteins.
- Published in:
- Rheumatology Advances in Practice, 2021, v. 5, n. 1, p. 1, doi. 10.1093/rap/rkaa083
- By:
- Publication type:
- Article
Serum markers of pulmonary epithelial damage in systemic sclerosis‐associated interstitial lung disease and disease progression.
- Published in:
- Respirology, 2021, v. 26, n. 5, p. 461, doi. 10.1111/resp.13988
- By:
- Publication type:
- Article
Exploring Anti-Fibrotic Effects of Adipose-Derived Stem Cells: Transcriptome Analysis upon Fibrotic, Inflammatory, and Hypoxic Conditioning.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 8, p. 693, doi. 10.3390/cells13080693
- By:
- Publication type:
- Article
Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma Skin.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 13, p. 1784, doi. 10.3390/cells12131784
- By:
- Publication type:
- Article
Induction of Pro-Fibrotic CLIC4 in Dermal Fibroblasts by TGF-β/Wnt3a Is Mediated by GLI2 Upregulation.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 3, p. 530, doi. 10.3390/cells11030530
- By:
- Publication type:
- Article
Exploring metabolism in scleroderma reveals opportunities for pharmacological intervention for therapy in fibrosis.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1004949
- By:
- Publication type:
- Article
Resolution of paraneoplastic PM/Scl-positive systemic sclerosis after curative resection of a pancreatic tumour.
- Published in:
- Rheumatology, 2017, v. 56, n. 2, p. 317, doi. 10.1093/rheumatology/kew382
- By:
- Publication type:
- Article
BSR and BHPR guideline for the treatment of systemic sclerosis.
- Published in:
- Rheumatology, 2016, v. 55, n. 10, p. 1906, doi. 10.1093/rheumatology/kew224
- By:
- Publication type:
- Article
Sustained benefit from intravenous immunoglobulin therapy for gastrointestinal involvement in systemic sclerosis.
- Published in:
- Rheumatology, 2016, v. 55, n. 1, p. 115, doi. 10.1093/rheumatology/kev318
- By:
- Publication type:
- Article
Old medications and new targeted therapies in systemic sclerosis.
- Published in:
- Rheumatology, 2015, v. 54, n. 11, p. 1944, doi. 10.1093/rheumatology/keu285
- By:
- Publication type:
- Article
Consensus best practice pathway of the UK Scleroderma Study Group: digital vasculopathy in systemic sclerosis.
- Published in:
- Rheumatology, 2015, v. 54, n. 11, p. 2015, doi. 10.1093/rheumatology/kev201
- By:
- Publication type:
- Article
Value of systolic pulmonary arterial pressure as a prognostic factor of death in the systemic sclerosis EUSTAR population.
- Published in:
- Rheumatology, 2015, v. 54, n. 7, p. 1262, doi. 10.1093/rheumatology/keu450
- By:
- Publication type:
- Article
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards.
- Published in:
- Rheumatology, 2015, v. 54, n. 1, p. 144, doi. 10.1093/rheumatology/keu288
- By:
- Publication type:
- Article
Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors.
- Published in:
- Rheumatology, 2013, v. 52, n. 10, p. 1824, doi. 10.1093/rheumatology/ket213
- By:
- Publication type:
- Article
Sustained improvement of diffuse systemic sclerosis following human cytomegalovirus infection offers insight into pathogenesis and therapy.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblasts.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Sustained improvement of diffuse systemic sclerosis following human cytomegalovirus infection offers insight into pathogenesis and therapy.
- Published in:
- Rheumatology, 2012, v. 51, n. 12, p. 2296, doi. 10.1093/rheumatology/kes137
- By:
- Publication type:
- Article
Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblasts.
- Published in:
- Rheumatology, 2012, v. 51, n. 12, p. 2146, doi. 10.1093/rheumatology/kes234
- By:
- Publication type:
- Article
Gut fibrosis with altered colonic contractility in a mouse model of scleroderma.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Gut fibrosis with altered colonic contractility in a mouse model of scleroderma.
- Published in:
- Rheumatology, 2012, v. 51, n. 11, p. 1989, doi. 10.1093/rheumatology/kes191
- By:
- Publication type:
- Article
Internal anal sphincter atrophy in patients with systemic sclerosis.
- Published in:
- 2011
- By:
- Publication type:
- Journal Article
Internal anal sphincter atrophy in patients with systemic sclerosis.
- Published in:
- Rheumatology, 2011, v. 50, n. 9, p. 1596, doi. 10.1093/rheumatology/ker153
- By:
- Publication type:
- Article
Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertension.
- Published in:
- Rheumatology, 2010, v. 49, n. 11, p. 2147, doi. 10.1093/rheumatology/keq241
- By:
- Publication type:
- Article
Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
- Published in:
- Rheumatology, 2010, v. 49, n. 11, p. 2024, doi. 10.1093/rheumatology/keq208
- By:
- Publication type:
- Article
Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre.
- Published in:
- Rheumatology, 2010, v. 49, n. 9, p. 1770, doi. 10.1093/rheumatology/keq147
- By:
- Publication type:
- Article
Comment on: A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Rosiglitazone alleviates the persistent fibrotic phenotype of lesional skin scleroderma fibroblasts.
- Published in:
- Rheumatology, 2010, v. 49, n. 2, p. 259, doi. 10.1093/rheumatology/kep371
- By:
- Publication type:
- Article
A longitudinal study of anti-RNA polymerase III antibody levels in systemic sclerosis.
- Published in:
- Rheumatology, 2009, v. 48, n. 10, p. 1218, doi. 10.1093/rheumatology/kep215
- By:
- Publication type:
- Article
Advances in pathogenesis and treatment of systemic sclerosis.
- Published in:
- Clinical Medicine, 2016, v. 16, n. 1, p. 55, doi. 10.7861/clinmedicine.16-1-55
- By:
- Publication type:
- Article
Advances in pathogenesis and treatment of systemic sclerosis.
- Published in:
- Clinical Medicine, 2015, v. 15, p. s58, doi. 10.7861/clinmedicine.15-6-s58
- By:
- Publication type:
- Article
Cardiac fibroblast-specific p38α MAP kinase promotes cardiac hypertrophy via a putative paracrine interleukin-6 signaling mechanism.
- Published in:
- FASEB Journal, 2018, v. 32, n. 9, p. 4941, doi. 10.1096/fj.201701455RR
- By:
- Publication type:
- Article
Treatment of Autoimmune Disease with Rabbit Anti-T Lymphocyte Globulin.
- Published in:
- Annals of the New York Academy of Sciences, 2007, v. 1110, p. 285, doi. 10.1196/annals.1423.030
- By:
- Publication type:
- Article
Validation of a protocol for the assessment of skin temperature and blood flow in childhood localised scleroderma.
- Published in:
- Skin Research & Technology, 2009, v. 15, n. 3, p. 346, doi. 10.1111/j.1600-0846.2009.00371.x
- By:
- Publication type:
- Article
SMAD inhibition attenuates epithelial to mesenchymal transition by primary keratinocytes in vitro.
- Published in:
- Experimental Dermatology, 2014, v. 23, n. 7, p. 497, doi. 10.1111/exd.12452
- By:
- Publication type:
- Article
Construct validity and reliability of the Assessment of Systemic Sclerosis-Associated Raynaud's Phenomenon (ASRAP) questionnaire.
- Published in:
- Rheumatology, 2024, v. 63, n. 5, p. 1281, doi. 10.1093/rheumatology/kead371
- By:
- Publication type:
- Article
Effects of nintedanib in patients with limited cutaneous systemic sclerosis and interstitial lung disease.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. 639, doi. 10.1093/rheumatology/kead280
- By:
- Publication type:
- Article
Prognostic and predictive markers of systemic sclerosis-associated interstitial lung disease in a clinical trial and long-term observational cohort.
- Published in:
- Rheumatology, 2024, v. 63, n. 2, p. 472, doi. 10.1093/rheumatology/kead234
- By:
- Publication type:
- Article
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature review.
- Published in:
- Rheumatology, 2023, v. 62, n. 12, p. 3785, doi. 10.1093/rheumatology/kead289
- By:
- Publication type:
- Article
'I turned in my man card': a qualitative study of the experiences, coping styles and support needs of men with systemic sclerosis.
- Published in:
- Rheumatology, 2023, v. 62, n. 6, p. 2160, doi. 10.1093/rheumatology/keac585
- By:
- Publication type:
- Article
Systemic sclerosis associated interstitial lung disease: a conceptual framework for subclinical, clinical and progressive disease.
- Published in:
- Rheumatology, 2023, v. 62, n. 5, p. 1877, doi. 10.1093/rheumatology/keac557
- By:
- Publication type:
- Article
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: data from the SENSCIS trial.
- Published in:
- Rheumatology, 2023, v. 62, n. 5, p. 1870, doi. 10.1093/rheumatology/keac535
- By:
- Publication type:
- Article
Macrophages as determinants and regulators of fibrosis in systemic sclerosis.
- Published in:
- Rheumatology, 2023, v. 62, n. 2, p. 535, doi. 10.1093/rheumatology/keac410
- By:
- Publication type:
- Article
genomic meta-analysis of clinical variables and their association with intrinsic molecular subsets in systemic sclerosis.
- Published in:
- Rheumatology, 2023, v. 62, n. 1, p. 19, doi. 10.1093/rheumatology/keac344
- By:
- Publication type:
- Article
Biological and clinical insights from a randomized phase 2 study of an anti-oncostatin M monoclonal antibody in systemic sclerosis.
- Published in:
- Rheumatology, 2023, v. 62, n. 1, p. 234, doi. 10.1093/rheumatology/keac300
- By:
- Publication type:
- Article
Nailfold capillaroscopy in SSc: innocent bystander or promising biomarker for novel severe organ involvement/progression?
- Published in:
- Rheumatology, 2022, v. 61, n. 11, p. 4384, doi. 10.1093/rheumatology/keac079
- By:
- Publication type:
- Article